Physician profile
Ilya Bendich
NPI 1225419617
$77,613.29
in general payments reported to CMS, 2019-2025
11 companies · $37K in 2025
The $37K reported for 2025 was more than what 86% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,131 · 2022: $651 · 2023: $1,041 · 2024: $37K · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $63K · Travel and Lodging: $4,898 · Food and Beverage: $4,636 · Long Term Medical Supply Or Device Loan: $2,782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $62,515.80 |
| Travel and Lodging | $4,897.53 |
| Food and Beverage | $4,636.36 |
| Long Term Medical Supply Or Device Loan | $2,782.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $35,262.08 | 2021-2025 | Real Intelligence, Journey II, K-15 Pork |
| Biocomposites INC | $18,635.68 | 2024-2025 | Stimulan |
| Medical Device Business Services, INC. | $13,676.98 | 2023-2025 | Velys, Actis |
| Stryker Corporation | $2,830.59 | 2021-2025 | Mako, Triathlon, Insignia |
| Zimmer Biomet Holdings, INC. | $2,782.24 | 2025 | Persona |
| Depuy Synthes Sales INC. | $2,360.32 | 2021-2025 | Attune, Actis |
| Encore Medical, LP | $1,357.72 | 2021 | |
| Orthalign INC | $385.58 | 2021-2025 | Orthalign Plus |
| Acera Surgical, INC. | $153.86 | 2025 | Restrata Wound Matrix |
| Linkbio Corp | $145.71 | 2025 | |
| Sanara Medtech INC. | $22.53 | 2024 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilya Bendich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.